Studies have identified a key oncogenic role for STAT3 in NSCLC: participating in the promotion of many cancer hallmarks, such as immune suppression, cell survival, angiogenesis, drug resistance, and cancer cell stemness [4]. The gene discussed is STAT3; the disease is cancer.